コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 rrhagic complications, optic disc edema, and dry eye syndrome.
2 erstand the mechanisms behind ocular pain in dry eye syndrome.
3 ement is a novel treatment for patients with dry eye syndrome.
4 pressing inflammatory responses occurring in dry eye syndrome.
5 dictive accuracy of 89% for the diagnosis of dry eye syndrome.
6 ficance on the healthy ocular surface and in dry eye syndrome.
7 rly estrogen alone, are at increased risk of dry eye syndrome.
8 have been diagnosed by a clinician as having dry eye syndrome.
9 Diabetes is also a major risk factor for dry eye syndrome.
10 st disease was a significant risk factor for dry eye syndrome.
11 ference or have been previously validated in dry eye syndromes.
12 nd CFTR activators as possible therapies for dry eye syndromes.
13 autions against use of mouse models of human dry eye syndromes.
14 ing to the development of new treatments for dry eye syndromes.
15 evalent ophthalmic irAEs in this cohort were dry eye syndrome (2%), conjunctivitis (0.87%), blepharit
17 on can result in tear film disorders such as dry eye syndrome, a widely encountered and debilitating
21 explore the visual health and prevalence of dry eye syndrome among university students in Iraq and J
22 patients (30 males, 66 females) with chronic dry eye syndrome and cataract, who had undergone phacoem
24 Objectives: To assess symptom progression in dry eye syndrome and determine risk factors associated w
25 lacritin may be selectively downregulated in dry eye syndrome and in blepharitis, yet little informat
27 t of ocular diseases affecting the anterior (dry eye syndrome) and posterior (age-related macular deg
28 surgery and who had not been diagnosed with dry eye syndrome at ours or another institution were inc
29 ating room predisposes surgical residents to dry eye syndrome because of environmental conditions.
30 ients with ophthalmic pathologies, including dry eye syndrome, blindness, and retinopathies, were mor
31 film and could influence the development of dry eye syndrome, but few data are available on this rel
33 atients with SLE and to evaluate the risk of dry eye syndrome, cataracts, glaucoma, episcleritis and
36 The aim was to investigate prevalence of dry eye syndrome (DES) in a population-based sample in G
43 nts with corneal diseases (12 patients each: dry eye syndrome [DES], contact lens wear, post-laser re
44 to determine the prevalence and severity of dry eye syndrome in a group of Mexican residents of diff
46 stance was the only variable associated with dry eye syndrome in the absence of DVH for the lachrymal
51 o pave the way for predictive diagnostics in dry eye syndrome, offering a robust platform for persona
53 ned end point of either clinically diagnosed dry eye syndrome or severe symptoms, the multivariable-a
57 s best supported by the literature include a dry eye syndrome similar to Sjogren syndrome, and ischem
58 d from the validated Short Questionnaire for Dry Eye Syndrome (SQDES) as a previous diagnosis of DED
59 se Index, together with diagnostic tests for dry eye syndrome, such as tear breakup time, Oxford Sche
66 ng a better understanding of the etiology of dry eye syndrome, which will inevitably lead to more eff
67 ecretion from the lacrimal gland can lead to dry eye syndromes with deleterious effects on vision.